29 September 2026 Biologics Clinical research Hidradenitis Suppurativa IBD risk stays low with IL-17 inhibitors in HS
4 August 2026 Biologics Gastroenterology Research Biologic dose escalation in IBD improves outcomes, reduces healthcare utilisation